Panel gene profiling of small bowel adenocarcinoma: Results from theNADEGEprospective cohort
- 13 November 2020
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 148 (7) , 1731-1742
Abstract
Small bowel adenocarcinoma (SBA) is a rare tumour. Large genomic analyses with prognostic assessments are lacking. The NADEGE cohort has enrolled 347 patients with all stage SBA from 2009 to 2012. Next‐generation sequencing investigates the presence of 740 hotspot somatic mutations in a panel of 46 genes involved in carcinogenesis. The mismatch repair (MMR) status was assessed by immunochemistry. We have collected 196 tumour samples and 125 had conclusive results for mutation analysis. The number of mutations was 0 in 9.6% of tumours, only 1 in 32.0%, 2 in 26.4% and ≥3 in 32.0%. Overall, at least one genomic alteration was observed in 90.4% of tumour. The most frequent genomic alteration was inKRAS(44.0%),TP53(38.4%),PIK3CA(20.0%),APC(18.4%),SMAD4(14.4%) andERBB2(7.2%) genes.KRASmutations were more frequent in synchronous metastatic tumours than in localised tumours (72.7% vs 38.2%,P= .003). There was no significant difference in the mutation rates according to primary location for the most frequently altered gene.ATM,FGFR3andFGFR1gene alterations were associated with Lynch syndrome andIDH1mutations with Crohn disease. dMMR tumours were associated with younger age, localised tumours, lessKRASbut moreSMARCB1mutations. No genomic alteration was associated with overall survival. There is a trend for better survival in patient with dMMR tumours. In conclusion, there is a different genomic alteration profile in SBA according to predisposing diseases. No association between genomic alterations and prognoses was observed except for a trend of better prognoses associated with dMMR.Keywords
This publication has 27 references indexed in Scilit:
- Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel DiseaseGastroenterology, 2016
- Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinomaLaboratory Investigation, 2016
- High prevalence of deficient mismatch repair phenotype and the V600E BRAF mutation in elderly patients with colorectal cancerJournal of Geriatric Oncology, 2014
- ERBB2 gene as a potential therapeutic target in small bowel adenocarcinomaEuropean Journal of Cancer, 2014
- Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatmentDigestive and Liver Disease, 2014
- Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002European Journal of Cancer, 2012
- Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancersAnnals of Oncology, 2011
- Intestinal Inflammation and CancerGastroenterology, 2011
- Epidemiology of cancer of the small intestineWorld Journal of Gastrointestinal Oncology, 2011
- ATM Polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) ageof onset (United States)Cancer Causes & Control, 2005